1. Sepanlou SG, Malekzadeh F, Naghavi M, Forouzanfar MH, Shahraz S, Moradi-Lakeh M, et al. Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010. Middle East J Dig Dis. 2015;7:121-37.
2. Pourhoseingholi MA, Vahedi M, Baghestani AR. Burden of gastrointestinal cancer in Asia; an overview. Gastroenterol Hepatol Bed Bench. 2015;8(1):19-27.
3. Malekzadeh F, Sepanlou SG, Poustchi H, Naghavi M, Forouzanfar MH, Shahraz S, et al. Burden of gastrointestinal and liver diseases in Iran: estimates based on the global burden of disease, injuries, and risk factors study, 2010. Middle East J Dig Dis. 2015;7:138-54.
4. Sepanlou SG, Malekzadeh F, Delavari F, Naghavi M, Forouzanfar MH, Moradi-Lakeh M, et al. Burden of gastrointestinal and liver diseases in Middle East and North Africa: results of global burden of diseases study from 1990 to 2010. Middle East J Dig Dis. 2015;7(4):201-15.
5. Fitzmaurice C. Burden of cancer in the Eastern Mediterranean Region, 2005–2015: findings from the Global Burden of Disease 2015 Study. Int J Public Health. 2017:1-14.
6. Naghavi M, Shahraz S, Sepanlou SG, BESc PN, Pourmalek F, Lozano R, et al. Health Transition in Iran toward Chronic Diseases Based on Results of Global Burden of Disease 2010. Arch Iran Med. 2014;17(5):321-35.
7. Darabi M, Lari MA, Motevalian SA, Motlagh A, Arsang-Jang S, Jaberi MK. Trends in gastrointestinal cancer incidence in Iran, 2001-2010: a joinpoint analysis. Epidemiology and Health. 2016;38.
8. Dong J, Thrift AP. Alcohol, smoking and risk of oesophago-gastric cancer. Best Pract Res Clin Gastroenterol. 2017;31(5):509-17.
9. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9(1):167.
10. Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord. 2017;16(1):3.
11. Nekouian R, Rasouli BS. Implementation of cancer prevention control program in private sector in Iran. J Cancer Policy. 2017;13:70-4.
12. MOHME. Summery of transformation and function program in health2016.
13. Walt G, Gilson L. Reforming the health sector in developing countries: the central role of policy analysis. Health Policy Plan. 1994;9(4):353-70.
14. Buse K, Mays N, Walt G. Making health policy: McGraw-Hill Education (UK); 2012.
15. MOHME. Basic interventions for non communicable diseases in Iranian primary health care "IraPEN". 2017.
16. MOHME. Implementation guide and educational concept for the prevention program of colorectal, breast amd uterine cancers. Tehran: Health affairs, non- communicable disease office2017.
17. MOHME. Comprehensive plan for cancer control. In: affairs h, editor.: MOHME; 2011.
18. DDRC. Clinical guideline for screening of colorectal cancer. 2015.
19. Salimzadeh H, Eftekhar H, Delavari A, Malekzadeh R. Psycho-social Determinants of Colorectal Cancer Screening in Iran. Int J Prev Med. 2014;5(2):185-90.
20. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (Clinical research ed). 2009 26;338:b929.
21. Golozar A, Etemadi A, Kamangar F, Fazeltabar Malekshah A, Islami F, Nasrollahzadeh D, et al. Food preparation methods, drinking water source, and esophageal squamous cell carcinoma in the high-risk area of Golestan, Northeast Iran. Eur J Cancer Prev. 2016;25(2):123-9.
22. Salimzadeh H, Bishehsari F, Sauvaget C, Amani M, Hamzehloo G, Nikfarjam A, et al. Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran. Arch Iran Med. 2017;20(12): 726-733.
23. Besharati F, Karimi-Shahanjarini A, Hazavehei SMM, Bashirian S, Bagheri F, Faradmal J. Development of a colorectal cancer screening intervention for Iranian adults: appling intervention mapping. Asian Pac J Cancer Prev. 2017;18(8):2193-99.
24. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, Taghavi N, et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer. 2004;90(7):1402-6.
25. Somi MH, Mirinezhad K, Farhang S, Jazayeri E, Sani A, Seif-Farshad M, et al. Gastrointestinal cancer occurrence in East Azarbaijan: a five year study from North Western Iran. Asian Pac J Cancer Prev. 2006;7(2):309-12.
26. Fatemi S, Moghimi B, Maserrat E, Zali M. Strategy of preventing colorectal cancer in the Iranian population. Journal of Medical Organization of Islamic Republic of Iran. 2010;28(4):444-9.
27. Hashemian M, Poustchi H, Abnet CC, Boffetta P, Dawsey SM, Brennan PJ, et al. Dietary intake of minerals and risk of esophageal squamous cell carcinoma: results from the Golestan Cohort Study. Am J Clin Nutr. 2015;102(1):102-8.
28. Roshandel G, Khoshnia M, Sotoudeh M, Merat S, Etemadi A, Nickmanesh A, et al. Endoscopic screening for precancerous lesions of the esophagus in a high risk area in Northern Iran. Arch Iran Med. 2014;17(4):246-52.
29. Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, et al. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study. Cancer epidemiology, biomarkers & prevention. 2018;27(3):268-73.
30. Kamangar F, Malekzadeh R, Dawsey SM, SAEIDI F. Esophageal cancer in Northeastern Iran: a review. Arch Iran Med. 2007;10(1):70-82.
31. Bridges JF, Gallego G, Blauvelt BM. Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs. Health Res Policy Syst. 2011 28;9-32.
32. Buchman S, Rozmovits L, Glazier RH. Equity and practice issues in colorectal cancer screening: Mixed-methods study. Can Fam Physician. 2016;62(4):e186-93.
33. Dawson G, Crane M, Lyons C, Burnham A, Bowman T, Perez D, et al. General practitioners' perceptions of population based bowel screening and their influence on practice: a qualitative study. BMC Fam Pract. 2017;18(1):36.
34. Goel V, Gray R, Chart P, Fitch M, Saibil F, Zdanowicz Y. Perspectives on colorectal cancer screening: A focus group study. Health Expect. 2004;7(1):51-60.
35. Jilcott Pitts SB, Lea CS, May CL, Stowe C, Hamill DJ, Walker KT, et al. "Fault-line of an earthquake": a qualitative examination of barriers and facilitators to colorectal cancer screening in rural, Eastern North Carolina. J Rural Health. 2013;29(1):78-87.
36. Priaulx J, de Koning HJ, de Kok IM, Széles G, McKee MJHP. Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST). Health Policy. 2018;122(11):1190-7.
37. Corthésy-Theulaz I, Porta N, Glauser M, Saraga E, Vaney A-C, Haas R, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology. 1995;109(1):115-21.
38. Blanchard TG, Czinn SJJGC. Current status and prospects for a Helicobacter pylori vaccine. Gastroenterol Clin North Am. 2015;44(3):677-89.
39. Bayo J, Molina R, Pérez J, Pérez-Ruíz E, Aparicio J, Beato C, et al. SEOM clinical guidelines to primary prevention of cancer (2018). Clin Transl Oncol. 2019;21(1):106-13.
40. Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;358(23):2468-81.
41. Uthman OA, Jadidi E, Moradi T. Socioeconomic position and incidence of gastric cancer: a systematic review and meta-analysis. J Epidemiol Community Health. 2013;67(10):854-60.
42. O’Connell S, Mc Carthy VJC, Savage EJBHSR. Frameworks for self-management support for chronic disease: a cross-country comparative document analysis. BMC Health Serv Res. 2018;18(1):583.
43. Pizzo E, Doyle C, Matthews R, Barlow J. Patient and public involvement: how much do we spend and what are the benefits? Health Expect. 2015;18(6):1918-26.